Company intelligence / Profile preview

Research Foundation for Microbial Diseases of Osaka University

Suita, Osaka, Japan

Ownership: Private
Employees: ~940
Development stage: Other

Overview

The BIKEN Foundation is a leading Japanese vaccine developer, manufacturer, and supplier, commercializing several combination pediatric vaccines and advancing mRNA and replicon RNA vaccine platforms for influenza and COVID-19. Products include approved combination vaccines such as GOBIK, with recent focus on licensing deals and innovation in RNA vaccine technologies[3][6].

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicmRNA-based drugsLive biotherapeutic product therapy
Industry: Biotech

Drug pipeline

12 assets

influenza A (H5N1) whole-virus vaccine

Approved

11 more assets in the full pipeline.

Request access →

Partnerships

VLPT JapanDenka

Beyond the preview

Go deeper on Research Foundation for Microbial Diseases of Osaka University.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Research Foundation for Microbial Diseases of Osaka University.

Explore the full profile